Video production for biotech
Most of what a biotech company is worth sits in unpublished data. The camera gets close to exactly the things nobody may talk about yet.
What this is about
Laboratories are graded by biosafety level, and the level decides who enters, in what clothing, with what equipment — some areas are off limits regardless of the story. What is visible inside them is the second layer: sample labels, notebook pages, screen contents and even instrument configurations can reveal pipeline details, so backgrounds are dressed or blurred by agreement, not by accident. For listed companies, wording is the third layer — statements about study progress or timelines touch capital-market communication rules and go through legal. The visual language leans on macro work, pipetting choreography and instrument detail, which needs planned time: honest lab beauty shots are slow to light.
Sector routine beats general experience: knowing the field's approval paths and constraints produces more realistic plans than more shoot days without that context.
What runs differently here
Where this differs from the general case:
- Biosafety levels gate access — crew, clothing and equipment are approved per lab, and some areas stay closed to cameras entirely
- Sample labels, notebooks and screens can leak pipeline information; backgrounds are dressed with cleared props before the crew arrives
- Statements about studies or timelines are capital-market relevant for listed companies and pass through legal word by word
- Real lab work cannot be re-run for coverage — assays have their own clocks, so hero shots are staged with dummy runs
- Publication and patent timing can embargo footage: what is filmable today may be showable only after a filing
What the plan has to deliver
A production plan is useful to this role when it provides the following:
- A lab access matrix — who may enter which level with which gear — settled before the schedule exists
- Dressed, cleared backgrounds and dummy samples prepared as props
- Approved wording for anything the film says about pipeline, studies or timelines
Common pitfalls
What most often goes wrong in practice:
- Filming real sample labels because nobody prepared dummies
- Letting a founder improvise timeline statements on camera
- Scheduling lab scenes against running assays that cannot pause
With TillyGen
TillyGen maps the briefing to scenes with access level, prop needs and approved wording attached, so the lab day runs on cleared material instead of improvisation.
Change one constraint and the consequences travel through the whole plan: affected shots are flagged, the call sheet is regenerated, and nobody keeps working from yesterday's version.
Frequently asked
Can we film in the actual research lab?
Usually in lower biosafety areas with approved clothing and equipment, and with backgrounds dressed in advance. Higher-level labs are typically represented by adjacent rooms, glass-wall shots or staged benches.
What may an investor film say about the pipeline?
Only wording legal has cleared — for listed companies, study and timeline statements touch capital-market communication. Lock the approved sentences before the interview, not in the edit.
How do we get authentic lab shots without disturbing research?
With dummy runs: real scientists, real instruments, prepared samples. It looks identical on camera and frees the shoot from assay clocks and contamination worries.
How long does it take to get started with TillyGen?
A first project takes under an hour to set up. There is no configuration phase in which templates and fields have to be defined before the tool produces anything.
Can the results be exported?
Yes — as PDF for the crew, CSV for downstream systems and through the API for anything automated. The plan stays the source; the exports are views of it.